NYSE:IGC | EBITDA | IGC Pharma, Inc.

Complete source-backed ebitda history.

Available history
2010-06-30 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$2.4M
2025-06-30-$1.76M
2025-03-31-$1.26M
2024-06-30-$2.23M
2024-03-31-$2.01M
2023-06-30-$1.98M
2023-03-31-$3.89M
2022-06-30-$2.64M
2022-03-31-$6.34M
2021-06-30-$2.04M
2021-03-31-$2.63M
2020-06-30-$1.85M
2020-03-31-$2.37M
2019-06-30-$1.44M
2019-03-31-$1.68M
2018-12-31-$1.56M
2018-09-30-$841,000.00
2018-06-30-$496,000.00
2018-03-31-$710,000.00
2017-12-31-$468,000.00
2017-09-30-$259,000.00
2017-06-30-$390,305.00
2017-03-31-$730,367.00
2016-12-31-$190,009.00
2016-09-30-$451,791.00
2016-06-30-$221,133.00
2016-03-31-$1.48M
2015-12-31-$232,000.00
2015-09-30-$359,366.00
2015-06-30-$101,363.00
2015-03-31-$1.6M
2014-12-31-$345,421.00
2014-09-30-$610,125.00
2014-06-30-$1M
2014-03-31-$1.27M
2013-12-31-$146,308.00
2013-09-30-$284,859.00
2013-06-30-$111,460.00
2013-03-31-$2.19M
2012-06-30-$110,539.00
2012-03-31-$4.22M
2011-06-30-$647,203.00
2011-03-31-$12.94M
2010-06-30-$435,865.00

Annual EBITDA

DateEBITDA
2025-03-31-$6.83M
2024-03-31-$9.16M
2023-03-31-$10.91M
2022-03-31-$14.78M
2021-03-31-$8.25M
2020-03-31-$6.72M
2019-03-31-$4.58M
2018-03-31-$1.77M
2017-03-31-$1.66M
2016-03-31-$2.18M
2015-03-31-$3.56M
2014-03-31-$1.82M
2013-03-31-$1.81M
2012-03-31-$6.52M
2011-03-31-$15.1M